Medicine Recommendations

Anxiety

Migraine prophylaxis

Schizophrenia, manic episodes associated with bipolar disorder, major depressive episodes in bipolar disorder, preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment.

Schizophrenia, manic episodes associated with bipolar disorder, major depressive episodes in bipolar disorder, preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, adjunct in major depressive disorder

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

MS (unlicensed)

Parkinson's disease

 Depressive illness

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Amyotrophic Lateral Sclerosis form of Motor Neurone Disease (NICE TA20)

NICE TA20 - Guidance on the Use of Riluzole (Rilutek) for the Treatment of Motor Neurone Disease 

Preventing migraine (NICE TA906)

NICE TA906 - Rimegepant for preventing migraine

Treating migraine (NICE TA919)

NICE TA919 - Rimegepant for treating migraine

Acute and chronic psychoses, mania; short-term treatment of persistent aggression in patients with moderate to severe Alzheimer's dementia unreponsive to non-pharmacological interventions and where there is a risk of harm to self or others; short-term treatment of persistent aggression in conduct disorder

MHRA Drug Safety Update - Drug name confusion

Schizophrenia

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

MHRA Drug Safety Update - Drug name confusion

MHRA Drug Safety Update - Risperidone and paliperidone: risk of floppy iris syndrome

Alzheimer's Dementia (NICE TA 217)

NICE TA217 - Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease

Restless Legs Syndrome (as per LSCMMG Guidelines)

Parkinsons disease

Restless Legs Syndrome (as per LSCMMG Guidelines)

Parkinsons Disease

Adjunct treatment of seizures in Lennox-Gastaut syndrome

MHRA Drug Safety Update - Antiepileptic drugs: updated advice on switching between different manufacturers’ products   

Treatment of adult patients with idiopathic Parkinson’s disease (PD) as add-on therapy to a stable dose of levodopa (L-dopa) alone or in combination with other PD medicinal products in mid to late stage fluctuating patients

Severe intractable insomnia only in patients already taking barbiturates

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.